A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054) (NCT05766501)

🧪 Interventions in This Study

• DOR/ISL (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (95 Sites)

Showing the first 25 of 95 sites.

• University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 3104) — Birmingham, Alabama
• Pueblo Family Physicians ( Site 3102) — Phoenix, Arizona
• Pacific Oaks Medical Group ( Site 3123) — Beverly Hills, California
• Kaiser Permanente ( Site 3124) — Los Angeles, California
• Ruane Clinical Research Group, Inc ( Site 3126) — Los Angeles, California
• Mills Clinical Research ( Site 3114) — Los Angeles, California
• University of California Davis Health-Internal Medicine: Infectious Diseases ( Site 3137) — Sacramento, California
• Georgetown University Medical Center ( Site 3130) — Washington D.C., District of Columbia
• Therafirst Medical Center ( Site 3110) — Fort Lauderdale, Florida
• Midway Immunology and Research Center ( Site 3117) — Ft. Pierce, Florida
• AHF The Kinder Medical Group ( Site 3108) — Miami, Florida
• Floridian Clinical Research, LLC ( Site 3133) — Miami Lakes, Florida
• Orlando Immunology Center ( Site 3106) — Orlando, Florida
• Bliss Healthcare Services ( Site 3115) — Orlando, Florida
• CAN Community Health - Sarasota ( Site 3118) — Sarasota, Florida
• Triple O Research Institute, P.A ( Site 3116) — West Palm Beach, Florida
• Augusta University-Infectious Diseases ( Site 3135) — Augusta, Georgia
• Infectious Disease Specialists of Atlanta ( Site 3128) — Decatur, Georgia
• Mercer university, Department of internal medicine-Clinical Research ( Site 3129) — Macon, Georgia
• Chatham County Health Department - Chatham CARE Center-Infectious Disease ( Site 3105) — Savannah, Georgia
• KC CARE Health Center ( Site 3103) — Kansas City, Missouri
• ID Care ( Site 3131) — Hillsborough, New Jersey
• Icahn School of Medicine at Mount Sinai-Clinical and Translational Research Center ( Site 3134) — New York, New York
• Penn Medicine: University of Pennsylvania Health System-Perelman Center for Advanced Medicine ( Site — Philadelphia, Pennsylvania
• St Hope Foundation ( Site 3121) — Bellaire, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in HIV Infection

• Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant — La Jolla, California
• Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption — Birmingham, Alabama
• Baricitinib Curative Repression of HIV-1 — Atlanta, Georgia
• Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy — Los Angeles, California
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study — La Jolla, California

Explore by condition: All HIV Infection clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.